To maximize anti-leukemic immunogenicity, ex vivo stimulation using a mix of IL-12, IL-15, and IL-18 provokes differentiation into memory-like NK cells, which exhibit enhanced leukemia-directed reactivity compared to non-activated/native NK cells [135,138]. The gene discussed is IL15; the disease is leukemia.